Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Aminoethylation-process-for-production-of-substituted-ethylene-diamines

 Peptide, process for its preparation and pharmaceutical composition containing same
We claim: 1. pGlu-Pro-Pro-Gly-Gly-Ser-Lys-Val-Ile-Leu-Phe. 2. A pharmaceutical composition for cell-...


 Stable pharmaceutical composition and method for its production
It is an object of the present invention to provide a stable pharmaceutical composition wherein the ...


 Pharmaceutical composition for treatment of adult respiratory distress syndrome containing human ANP
The present invention has been accomplished under these circumstances and has as an object ...


 Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
OF THE PREFERRED EMBODIMENT The following standard abbreviations for the amino acid residues are ...


 Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX
The invention provides an isolated peptide that functionally mimics a binding site for a ...


 Adjuvant and vaccine compositions containing monophosphoryl lipid A
What is claimed: 1. A lyophilized composition comprising 0.2% up to 5% by weight 3-O-desacyl-4'-...


 Methods for preparation of vaccines against cancer
The present invention relates to methods for producing increased amounts of immunogenic material ...


 Human genes and gene expression products V
OF THE INVENTION The invention relates to polynucleotides comprising the disclosed nucleotide ...


 Haptotactic peprides
The invention claimed is: 1. An isolated haptotactic peptide of 20 amino acids consisting of the ...


 Hepatitis C virus inhibitors
OF THE INVENTION Stereochemical definitions and conventions used herein generally follow McGraw-H...


 Aminoethylation process for production of substituted ethylene diamines

Details
Inventors: Rooney, Peter C.; Nutt, Michael O.;
Assignee: The Dow Chemical Company (Midland, MI)
Primary Examiner: Hollrah; Glennon H.
Assistant Examiner: Rand; Scott C.
Attorney, Agent or Firm:

A process is disclosed for producing a substituted ethylenediamine, the process comprising reacting an oxazolidinone with a secondary amine or an alkanolamine. The process includes, in one aspect, reacting precursors of the oxazolidinone in situ.

DETAILED DESCRIPTION What is claimed is: 1.
A process for preparing a 1,2-ethanediamine in a ring opening reaction of an oxazolidinone, the process comprising contacting an oxazolidinone with an aliphatic secondary amine or an aliphatic secondary alkanolamine to effect reaction of the oxazolidinone with the aliphatic secondary amine or aliphatic secondary alkanolamine for a sufficient time to form a 1,2-ethanediamine.
2.
The process of claim 1 wherein the oxazolidinone is a 2-oxazolidinone corresponding to the formula ##STR13## wherein R' is selected from the group consisting of hydrogen, C1-20 hydrocarbyl, C6-20 aryl, C6-20 aralkyl, C1-20 hydroxyhydrocarbyl, C6-20 aralkyl, C1-20 alkyl, C1-20 hydroxyalkyl, C1-10 alkyl, C1-10 hydroxyalkyl, phenyl, methyl, ethyl, and 2-hydroxyethyl and R.
sup.
2 is selected from the group consisting of hydrogen, C1-20 alkyl, C1-20 alkenyl, C6-20 aryl, C6-20 aralkyl, and C1-20 hydrocarbyl.
3.
The process of claim 2 wherein the 2-oxazolidinone is selected from the group consisting of 3-methyl-2-oxazolidinone, 3-phenyl-2-oxazolidinone, 3-(2-hydroxypropyl-5-methyl-2-oxazolidinone), 3-(2-hydroxyethyl)-2-oxazolidinone and 2-oxazolidone, and mixtures thereof.
4.
The process of claim 1 wherein the aliphatic secondary alkanolamine is diethanolamine, monomethylethanolamine or diisopropanolamine.
5.
The process of claim 1 wherein the aliphatic secondary amine is of the formula R.
sup.
3 R.
sup.
4 NH wherein R.
sup.
3 and R.
sup.
4 are a C1-20 alkyl or C1-20 aralkyl.
6.
The process in claim 1 wherein the process is conducted at a temperature between about 20.
degree.
C.
and 280.
degree.
C.
7.
The process in claim 1 wherein the process is conducted at a temperature between about 90.
degree.
C.
and 210.
degree.
C.
8.
The process in claim 1 wherein the process is conducted at a temperature between about 120.
degree.
C.
and 180.
degree.
C.
9.
The process of claim 1 wherein an excess of a secondary amine or of a secondary alkanolamine is provided for the process.
10.
The process of claim 1 further comprising reacting precursors of the oxazolidinone to produce the oxazolidinone, then reacting the oxazolidinone with the secondary amine or the alkanolamine



Related patents
  Transdermal thermal polymerization
The present invention, in one aspect, is a method for polymerizing or crosslinking by transdermal thermal energy a perpolymer which has been placed in the body of an ...
  Method for identifying an oligonucleotide aptamer specific for a target
We claim: 1. A method for identifying an aptamer which specifically binds to thrombin, wherein the aptamer comprises the sequence 5' GGNTGG 3' wherein N is A, T Or G ...
  Plant transcription regulators from circovirus
OF THE INVENTION The present invention is further described by reference to the following non-limiting figures and/or examples. Reference herein to a promoter region ...
  Methods for modulation of the effects of aging on the primate brain
The invention provides a clinically useful protocol for delivery of recombinant nervous system growth factors into the aging mammalian brain. The invention is ...
  Genetic engineering of cells to enhance healing and tissue regeneration
OF THE INVENTION It has been discovered that cells can be genetically engineered to produce bioactive molecules which act on the cells that are expressing the molecules,...
  Vascular endothelial growth factor-D (VEGF-D) polypeptides
OF THE INVENTION The invention will now be described in detail by reference to the figures, and to the following non-limiting examples. EXAMPLE 1 It has been speculated ...
  Methods for treating viral infection using IL-28 and IL-29
We claim: 1. A method of treating a viral infection comprising administering to an immunocompromised mammal with a hepatitis infection a therapeutically effective amount ...
  Method of manufacturing an electrohydraulic probe
OF THE INVENTION Referring to FIG. 1 there is shown a diagrammatical view of the bladder 2, ureter 4 and kidney 6 areas of a patient having a lithotriptoscope 8 moving ...
  Releasable linkage and compositions containing same
Accordingly, it is an object of the invention to provide a compound where a ligand is covalently yet reversibly linked to a hydrophilic polymer. Upon cleavage of the ...
  Solid phase dispersion of quinolone or naphthyridonecarboxylic acids
What is claimed is: 1. A solid phase dispersion comprising a micronized quinolinecarboxylic acid or micronized naphthyridonecarboxylic acid in an insoluble matrix, ...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved